British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)

Research output: Contribution to journalReview articlepeer-review

Standard

British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU). / Newton, Claire; Nordin, Andy; Rolland, Philip; Ind, Thomas; Larsen-Disney, Peter; Martin-Hirsch, Pierre; Beaver, Kinter; Bolton, Helen; Peevor, Richard; Fernandes, Andrea; Kew, Fiona; Sengupta, Partha; Miles, Tracie; Buckley, Lynn; Manderville, Helen; Gajjar, Ketan; Morrison, Jo; Ledermann, Jonathan; Frost, Jonathan; Lawrence, Alexandra; Sundar, Sudha; Fotopoulou, Christina.

In: International Journal of Gynecological Cancer, Vol. 30, No. 5, 04.05.2020, p. 695-700.

Research output: Contribution to journalReview articlepeer-review

Harvard

Newton, C, Nordin, A, Rolland, P, Ind, T, Larsen-Disney, P, Martin-Hirsch, P, Beaver, K, Bolton, H, Peevor, R, Fernandes, A, Kew, F, Sengupta, P, Miles, T, Buckley, L, Manderville, H, Gajjar, K, Morrison, J, Ledermann, J, Frost, J, Lawrence, A, Sundar, S & Fotopoulou, C 2020, 'British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)', International Journal of Gynecological Cancer, vol. 30, no. 5, pp. 695-700. https://doi.org/10.1136/ijgc-2019-001176

APA

Newton, C., Nordin, A., Rolland, P., Ind, T., Larsen-Disney, P., Martin-Hirsch, P., Beaver, K., Bolton, H., Peevor, R., Fernandes, A., Kew, F., Sengupta, P., Miles, T., Buckley, L., Manderville, H., Gajjar, K., Morrison, J., Ledermann, J., Frost, J., ... Fotopoulou, C. (2020). British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU). International Journal of Gynecological Cancer, 30(5), 695-700. https://doi.org/10.1136/ijgc-2019-001176

Vancouver

Author

Newton, Claire ; Nordin, Andy ; Rolland, Philip ; Ind, Thomas ; Larsen-Disney, Peter ; Martin-Hirsch, Pierre ; Beaver, Kinter ; Bolton, Helen ; Peevor, Richard ; Fernandes, Andrea ; Kew, Fiona ; Sengupta, Partha ; Miles, Tracie ; Buckley, Lynn ; Manderville, Helen ; Gajjar, Ketan ; Morrison, Jo ; Ledermann, Jonathan ; Frost, Jonathan ; Lawrence, Alexandra ; Sundar, Sudha ; Fotopoulou, Christina. / British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU). In: International Journal of Gynecological Cancer. 2020 ; Vol. 30, No. 5. pp. 695-700.

Bibtex

@article{79559f0edcdc482f98feeb787195f31a,
title = "British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)",
abstract = "The National Cancer Survivorship Initiative through the National Health Service (NHS) improvement in the UK started the implementation of stratified pathways of patient-initiated follow-up (PIFU) across various tumor types. Now the initiative is continued through the Living With and Beyond Cancer program by NHS England. Evidence from non-randomized studies and systematic reviews does not demonstrate a survival advantage to the long-established practice of hospital-based follow-up regimens, traditionally over 5 years. Evidence shows that patient needs are inadequately met under the traditional follow-up programs and there is therefore an urgent need to adapt pathways to the needs of patients. The assumption that hospital-based follow-up is able to detect cancer recurrences early and hence improve patient prognosis has not been validated. A recent survey demonstrates that follow-up practice across the UK varies widely, with telephone follow-up clinics, nurse-led clinics and PIFU becoming increasingly common. There are currently no completed randomized controlled trials in PIFU in gynecological malignancies, although there is a drive towards implementing PIFU. PIFU aims to individualize patient care, based on risk of recurrence and holistic needs, and optimizing resources. The British Gynaecological Cancer Society wishes to provide the gynecological oncology community with guidance and a recommendations statement regarding the value, indications, and limitations of PIFU in endometrial, cervical, ovarian, and vulvar cancers in an effort to standardize practice and improve patient care.",
keywords = "follow-up (FU), gynaecological malignancies, gynaecology oncology, patient initiated follow-up (PIFU)",
author = "Claire Newton and Andy Nordin and Philip Rolland and Thomas Ind and Peter Larsen-Disney and Pierre Martin-Hirsch and Kinter Beaver and Helen Bolton and Richard Peevor and Andrea Fernandes and Fiona Kew and Partha Sengupta and Tracie Miles and Lynn Buckley and Helen Manderville and Ketan Gajjar and Jo Morrison and Jonathan Ledermann and Jonathan Frost and Alexandra Lawrence and Sudha Sundar and Christina Fotopoulou",
year = "2020",
month = may,
day = "4",
doi = "10.1136/ijgc-2019-001176",
language = "English",
volume = "30",
pages = "695--700",
journal = "International Journal of Gynecological Cancer",
issn = "1525-1438",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)

AU - Newton, Claire

AU - Nordin, Andy

AU - Rolland, Philip

AU - Ind, Thomas

AU - Larsen-Disney, Peter

AU - Martin-Hirsch, Pierre

AU - Beaver, Kinter

AU - Bolton, Helen

AU - Peevor, Richard

AU - Fernandes, Andrea

AU - Kew, Fiona

AU - Sengupta, Partha

AU - Miles, Tracie

AU - Buckley, Lynn

AU - Manderville, Helen

AU - Gajjar, Ketan

AU - Morrison, Jo

AU - Ledermann, Jonathan

AU - Frost, Jonathan

AU - Lawrence, Alexandra

AU - Sundar, Sudha

AU - Fotopoulou, Christina

PY - 2020/5/4

Y1 - 2020/5/4

N2 - The National Cancer Survivorship Initiative through the National Health Service (NHS) improvement in the UK started the implementation of stratified pathways of patient-initiated follow-up (PIFU) across various tumor types. Now the initiative is continued through the Living With and Beyond Cancer program by NHS England. Evidence from non-randomized studies and systematic reviews does not demonstrate a survival advantage to the long-established practice of hospital-based follow-up regimens, traditionally over 5 years. Evidence shows that patient needs are inadequately met under the traditional follow-up programs and there is therefore an urgent need to adapt pathways to the needs of patients. The assumption that hospital-based follow-up is able to detect cancer recurrences early and hence improve patient prognosis has not been validated. A recent survey demonstrates that follow-up practice across the UK varies widely, with telephone follow-up clinics, nurse-led clinics and PIFU becoming increasingly common. There are currently no completed randomized controlled trials in PIFU in gynecological malignancies, although there is a drive towards implementing PIFU. PIFU aims to individualize patient care, based on risk of recurrence and holistic needs, and optimizing resources. The British Gynaecological Cancer Society wishes to provide the gynecological oncology community with guidance and a recommendations statement regarding the value, indications, and limitations of PIFU in endometrial, cervical, ovarian, and vulvar cancers in an effort to standardize practice and improve patient care.

AB - The National Cancer Survivorship Initiative through the National Health Service (NHS) improvement in the UK started the implementation of stratified pathways of patient-initiated follow-up (PIFU) across various tumor types. Now the initiative is continued through the Living With and Beyond Cancer program by NHS England. Evidence from non-randomized studies and systematic reviews does not demonstrate a survival advantage to the long-established practice of hospital-based follow-up regimens, traditionally over 5 years. Evidence shows that patient needs are inadequately met under the traditional follow-up programs and there is therefore an urgent need to adapt pathways to the needs of patients. The assumption that hospital-based follow-up is able to detect cancer recurrences early and hence improve patient prognosis has not been validated. A recent survey demonstrates that follow-up practice across the UK varies widely, with telephone follow-up clinics, nurse-led clinics and PIFU becoming increasingly common. There are currently no completed randomized controlled trials in PIFU in gynecological malignancies, although there is a drive towards implementing PIFU. PIFU aims to individualize patient care, based on risk of recurrence and holistic needs, and optimizing resources. The British Gynaecological Cancer Society wishes to provide the gynecological oncology community with guidance and a recommendations statement regarding the value, indications, and limitations of PIFU in endometrial, cervical, ovarian, and vulvar cancers in an effort to standardize practice and improve patient care.

KW - follow-up (FU)

KW - gynaecological malignancies

KW - gynaecology oncology

KW - patient initiated follow-up (PIFU)

UR - http://www.scopus.com/inward/record.url?scp=85083712879&partnerID=8YFLogxK

U2 - 10.1136/ijgc-2019-001176

DO - 10.1136/ijgc-2019-001176

M3 - Review article

C2 - 32312719

AN - SCOPUS:85083712879

VL - 30

SP - 695

EP - 700

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1525-1438

IS - 5

ER -